Combination Gefitinib and Methotrexate to Medically Treat Ectopic Pregnancies: A Phase II Study of Efficacy

Phase 2

Recruiting

• Conditions: Clinically stable ectopic pregnancies; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders

• Registration Number: ACTRN12611001056987
• Lead Sponsor: Associate Professor Stephen Tong

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

Women diagnosed with a haemodynamically stable ectopic pregnancy with any level of pre-treatment serum hCG.

Exclusion Criteria

Haemodynamic instability, women of Japanese ethnicity, chronic and/or severe history of lung disease including lung cancer history, history of severe gastrointestinal and dermatological conditions, hepatic or renal dysfunction on screening blood tests, allergy to gefitinib/methotrexate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified